Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 3Terminated 2Unknown 1Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Melanoma 1

Interventions

Nivolumab 7pembrolizumab 4Ipilimumab 4cemiplimab 3relatlimab 2Watchful Waiting 2Standard of Care 2Specimen Handling 2Prednisone 2Photochemotherapy 2Melphalan 2Magnetic Resonance Spectroscopy 2Interleukin-2 2Dermoscopy 2Cryotherapy 2Carboplatin 2vedolizumab 1trametinib 1toripalimab 1tirbanibulin 1sulforaphane 1gadopiclenol 1famitinib 1decitabine and cedazuridine drug combination 1daromun 1calcipotriene 1anlotinib 1X-Rays 1Vitamin D 1Vincristine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Toll-Like Receptor 1 × Dermatologic × Clear all
NCT07406724 2026-02-12

HS-IT101 Injection Versus Chemotherapy in the Treatment of Advanced Melanoma

Qingdao Sino-Cell Biomedicine Co., Ltd.

Phase 2 Not yet recruiting
90 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡